Cite
HARVARD Citation
Jabbour, E. et al. (2017). Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B‐cell acute lymphoblastic leukemia. Cancer. 123 (2), pp. 294-302. [Online].